| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 67,215 | 56,461 | 50,284 | | Cost of Revenue | 9,008 | 7,703 | 6,427 | | | Gross Profit | 58,207 | 48,758 | 43,857 | | | Operating Expenses | | Research Development | 6,125 | 10,101 | 4,843 | | Selling General and Administrative | 44,177 | 50,314 | 33,499 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,905 | (11,657) | 5,515 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 101 | (38) | 127 | | Earnings Before Interest And Taxes | 8,006 | (11,695) | 5,642 | | Interest Expense | 9 | 24 | 315 | | Income Before Tax | 7,997 | (11,719) | 5,327 | | Income Tax Expense | 2,694 | (4,427) | 2,132 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,303 | (7,292) | 3,195 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,303 | (7,292) | 3,195 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,303 | ($7,292) | $3,195 |
|
0.51% Nasdaq 
Income Statement
